{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:38:26Z","timestamp":1793705906634,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1743-422x-10-360","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T12:02:36Z","timestamp":1387800156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy"],"prefix":"10.1186","volume":"10","author":[{"given":"Raisa","family":"Perzova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Sanghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Lalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sheremata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J","family":"Poiesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980, 77: 7415-7419.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1126\/science.6981847","volume":"218","author":"VS Kalyanaraman","year":"1982","unstructured":"Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982, 218: 4571-4573.","journal-title":"Science"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, et al.: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2: 407-409.","journal-title":"Lancet"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0140-6736(92)90797-7","volume":"339","author":"B Hjelle","year":"1992","unstructured":"Hjelle B, Appenzeller O, Mills R, et al.: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992, 339: 645-646.","journal-title":"Lancet"},{"key":"2346_CR5","first-page":"1096","volume":"3","author":"JE Kaplan","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, et al.: The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990, 3: 1096-1101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","volume":"61","author":"JR Orland","year":"2003","unstructured":"Orland JR, Engstrom J, Fridey J, et al.: Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology 2003, 61: 1588-1594.","journal-title":"Neurology"},{"key":"2346_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano Y, Nagai M, Brennan M, et al.: Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood 2002, 99: 88-94.","journal-title":"Blood"},{"key":"2346_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM198805053181801","volume":"318","author":"S Bhagavati","year":"1988","unstructured":"Bhagavati S, Ehrlich G, Kula RW, et al.: Detection of human T-cell lymphoma\/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 1988, 318: 1141-1147.","journal-title":"N Engl J Med"},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ana.410330416","volume":"33","author":"WJ Harrington","year":"1993","unstructured":"Harrington WJ, Sheremata W, Hjelle B, et al.: Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993, 33: 441-414.","journal-title":"Ann Neurol"},{"key":"2346_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/13550289709015802","volume":"3","author":"MC Levin","year":"1997","unstructured":"Levin MC, Jacobson S: HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 1997, 3: 126-140.","journal-title":"J Neurovirol"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/187152808785107642","volume":"4","author":"DU Goncalves","year":"2008","unstructured":"Goncalves DU, Proietti FA, Barbosa-Stancioli EF, et al.: HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) inflammatory network. Inflamm Allergy Drug Targets 2008, 4: 98-107.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2346_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000026194","volume":"18","author":"GW Lowis","year":"1999","unstructured":"Lowis GW, Sheremata WA, Wickman PR, Dube S, Dube K, Poiesz BJ: HTLV-II risk factors in Native Americans in Florida. Neuroepidemiology 1999, 18: 37-47.","journal-title":"Neuroepidemiology"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/aid.2009.0124","volume":"26","author":"A Thomas","year":"2010","unstructured":"Thomas A, Perzova R, Abbott L, Benz P, et al.: LGL leukemia and HTLV. AIDS Res Hum Retro 2010, 26: 33-40.","journal-title":"AIDS Res Hum Retro"},{"key":"2346_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ygeno.2005.06.004","volume":"86","author":"DL Moyes","year":"2005","unstructured":"Moyes DL, Martin A, Sawcer S, Temperton N, et al.: The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 2005, 86: 337-341.","journal-title":"Genomics"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.410260304","volume":"26","author":"M Yoshida","year":"1989","unstructured":"Yoshida M, Osame M, Kawai H, et al.: Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989, 26: 331-335.","journal-title":"Ann Neurol"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/423942","volume":"190","author":"AH Sabouri","year":"2004","unstructured":"Sabouri AH, Saito M, Lloyd AL, et al.: Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 2004, 190: 1279-1285.","journal-title":"J Infect Dis"},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis343","volume":"55","author":"A Trevi\u00f1o","year":"2012","unstructured":"Trevi\u00f1o A, Lopez M, Vispo E, et al.: Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms. Clin Infect Dis 2012, 55: e1-e4.","journal-title":"Clin Infect Dis"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood-2008-02-140335","volume":"112","author":"AH Sabouri","year":"2008","unstructured":"Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, Saito M: Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood 2008, 112: 2411-2420.","journal-title":"Blood"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999, 96: 3848-3853.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jnr.20137","volume":"77","author":"F Kalume","year":"2004","unstructured":"Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC: Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res 2004, 77: 82-89.","journal-title":"J Neurosci Res"},{"key":"2346_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM, Birren B, et al.: Initial sequencing and analysis of the human genome. Nature 2001, 409: 860-921.","journal-title":"Nature"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/sj.leu.2402355","volume":"16","author":"S Depil","year":"2002","unstructured":"Depil S, Roche C, Dussart P, Prin L: Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 2002, 16: 254-259.","journal-title":"Leukemia"},{"key":"2346_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.exphem.2004.03.003","volume":"32","author":"D Morgan","year":"2004","unstructured":"Morgan D, Brodsky I: Human endogenous retrovirus (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp Hematol 2004, 32: 520-525.","journal-title":"Exp Hematol"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/art.1780400407","volume":"40","author":"K Nakagawa","year":"1997","unstructured":"Nakagawa K, Brusic V, McColl G, Harrison LC: Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum 1997, 40: 627-638.","journal-title":"Arthritis Rheum"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1365-2249.2002.01735.x","volume":"128","author":"CA Herve","year":"2002","unstructured":"Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJ: Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol 2002, 128: 75-82.","journal-title":"Clin Exp Immunol"},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1099\/0022-1317-80-1-255","volume":"80","author":"ML Andersson","year":"1999","unstructured":"Andersson ML, Lindeskog M, Medstrand P, Westley B, May F, Bloomberg J: Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol 1999, 80: 255-260.","journal-title":"J Gen Virol"},{"key":"2346_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2164-9-354","volume":"9","author":"A Flockerzi","year":"2008","unstructured":"Flockerzi A, Ruggieri A, Frank O, et al.: Expression patterns of transcribed human endogenous retrovirus HERV-K (HML-2) loci in human tissues and the need for a HERV transcriptome project. BMC Genomics 2008, 9: 354.","journal-title":"BMC Genomics"},{"key":"2346_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-5751-12-3","volume":"12","author":"RB Jones","year":"2013","unstructured":"Jones RB, Leal FE, Hasenkrug AM, et al.: Human endogenous retrovirus K (HML-2) Gag and Env specific T-cells responses are not detected in HTLV-I-infected subjects using standard peptide screening methods. J Negat Results Biomed 2013, 12: 3.","journal-title":"J Negat Results Biomed"},{"key":"2346_CR29","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1371\/journal.ppat.0030165","volume":"3","author":"KE Garrison","year":"2007","unstructured":"Garrison KE, Jones RB, Meikejohn DA, et al.: T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007, 3: e165.","journal-title":"PLoS Pathog"},{"key":"2346_CR30","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.1128\/JVI.00179-11","volume":"85","author":"D SenGupta","year":"2011","unstructured":"SenGupta D, Tandon R, Vieria RG, et al.: Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol 2011, 85: 6977-6985.","journal-title":"J Virol"},{"key":"2346_CR31","doi-asserted-by":"publisher","first-page":"11526","DOI":"10.1128\/JVI.05418-11","volume":"85","author":"R Tandon","year":"2011","unstructured":"Tandon R, SenGupta D, Ndhlovu LC, et al.: Identification of human endogenous retrovirus specific T-cell responses in vertically HIV-1 infected subjects. J Virol 2011, 85: 11526-11531.","journal-title":"J Virol"},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1128\/JVI.02115-07","volume":"82","author":"O Frank","year":"2008","unstructured":"Frank O, Verbeke C, Schwarz N, et al.: Variable transcriptional activity of endogenous retroviruses in human breast cancer. J Virol 2008, 82: 1808-1818.","journal-title":"J Virol"},{"key":"2346_CR33","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1128\/JVI.00646-08","volume":"82","author":"R Contreras-Galindo","year":"2008","unstructured":"Contreras-Galindo R, Kaplan MH, Leissner P, et al.: Human endogenous retrovirus K (HML-2) elements is the plasma of people with lymphoma and breast cancer. J Virol 2008, 82: 9329-9336.","journal-title":"J Virol"},{"key":"2346_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2249.2010.04110.x","volume":"160","author":"G Freimanis","year":"2010","unstructured":"Freimanis G, Hooley P, Ejtehadi HD, et al.: A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol 2010, 160: 340-347.","journal-title":"Clin Exp Immunol"},{"key":"2346_CR35","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/v3112146","volume":"3","author":"C Tofaily","year":"2011","unstructured":"Tofaily C, Landry S, Leib-Mosch C, Rassart E, Barbeau B: Activation of LTRs form different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Viruses 2011, 3: 2146-2159.","journal-title":"Viruses"},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","volume":"11","author":"L Sokol","year":"2006","unstructured":"Sokol L, Loughran TP Jr: Large granular lymphocyte leukemia. Oncologist 2006, 11: 263-273.","journal-title":"Oncologist"},{"key":"2346_CR37","first-page":"382","volume":"64","author":"WHO","year":"1989","unstructured":"WHO: Virus diseases: human T-lymphotropic virus type I (HTLV-I). Wkly Epidemiol Rec 1989, 64: 382.","journal-title":"Wkly Epidemiol Rec"},{"key":"2346_CR38","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1086\/429962","volume":"191","author":"A Lezin","year":"2005","unstructured":"Lezin A, Olindo S, Oliere S, et al.: Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis? J Infec Dis 2005, 191: 1830-1834.","journal-title":"J Infec Dis"},{"key":"2346_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, et al.: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69: 292-302.","journal-title":"Ann Neurol"},{"key":"2346_CR40","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood.V80.5.1116.1116","volume":"80","author":"TP Loughran Jr","year":"1992","unstructured":"Loughran TP Jr, Coyle T, Sherman MP, et al.: Detection of human T-cell leukemia\/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992, 80: 1116-1119.","journal-title":"Blood"},{"key":"2346_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/infdis\/165.2.268","volume":"165","author":"JJ Lipka","year":"1992","unstructured":"Lipka JJ, Miyoshi I, Hadlock KG, et al.: Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis 1992, 165: 268-272.","journal-title":"J Infect Dis"},{"key":"2346_CR42","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V74.5.1658.1658","volume":"74","author":"GD Ehrlich","year":"1989","unstructured":"Ehrlich GD, Glaser JB, LaVigne K, et al.: Prevalence of human T-cell leukemia\/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood 1989, 74: 1658-1664.","journal-title":"Blood"},{"key":"2346_CR43","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1073\/pnas.0307885100","volume":"101","author":"JF Hughes","year":"2004","unstructured":"Hughes JF, Coffin JM: Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Natl Acad Sci USA 2004, 101: 1668-1672.","journal-title":"Natl Acad Sci USA"},{"key":"2346_CR44","volume-title":"Statistics to use","author":"TW Kirkman","year":"1996","unstructured":"Kirkman TW: Statistics to use. 1996. (21 May 2012) http:\/\/www.physics.csbsju.edu\/stats\/"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:35:24Z","timestamp":1630550124000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-360","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"12 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"360"}}